Skip to main content
CHEIL BIO CO., LTD. logo

CHEIL BIO CO., LTD. — Investor Relations & Filings

Ticker · 052670 ISIN · KR7052670007 KO Manufacturing
Filings indexed 291 across all filing types
Latest filing 2025-04-17 Delisting Announcement
Country KR South Korea
Listing KO 052670

About CHEIL BIO CO., LTD.

http://www.cheilbio.com/en/index.php

CHEIL BIO CO., LTD. is a company that develops, manufactures, and markets a wide range of advanced veterinary products. The company focuses on improving the health and productivity of livestock through solutions based on extensive research and biotechnology. Its core offerings include animal medicines, such as antibiotics and antimicrobials, and functional feed additives. These products cater to a diverse market, including the swine, poultry, cattle, and aquaculture sectors, as well as companion animals. The company leverages its dedicated research and development capabilities to create high-quality, market-competitive products and aims to achieve global technological competitiveness in the animal health industry.

Recent filings

Filing Released Lang Actions
기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)
Delisting Announcement Classification · 100% confidence The document is a short regulatory announcement from the Korea Exchange regarding the status of a company's listing (delisting process) following an 'opinion disclaimer' from auditors. It does not contain the full financial report or audit report itself, but rather serves as a formal notice of regulatory proceedings and timelines. Given the nature of the content regarding listing status and regulatory oversight, it fits best under the RNS (Regulatory Filings) category as a general regulatory announcement.
2025-04-17 Korean
사업보고서 (2024.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Jeil Bio Co., Ltd. for the fiscal year ending December 31, 2024. It includes the independent auditor's report, financial statements (balance sheet, income statement, etc.), and detailed notes. It is not an annual report (10-K) as it focuses specifically on the audit results and financial statements, and it is not an announcement (RPA) because it contains the full financial data and audit opinion (which is a disclaimer of opinion). Therefore, it is classified as an Audit Report. FY 2024
2025-04-07 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the fiscal year 2024, filed by CheilBio Co., Ltd. It contains comprehensive financial and operational information, including company history, management changes, capital structure, and business descriptions. This is a standard annual regulatory filing in South Korea, which corresponds to the '10-K' category in the provided schema. FY 2024
2025-04-07 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) submitted to the Korea Exchange (KRX). It provides the auditor's opinion (which is 'disclaimer of opinion' or '의견거절'), key financial data, and details regarding the audit process. While it contains financial data, it is a specific regulatory disclosure regarding the audit outcome rather than a full Annual Report (10-K) or a simple announcement of a report (RPA). It fits the definition of an Audit Report/Information (AR) as it focuses on the results of the audit and accounting opinions. FY 2024
2025-04-04 Korean
기타시장안내 (상장폐지 관련)
Delisting Announcement Classification · 100% confidence The document is an official notice from the KOSDAQ market regarding the delisting process of 'Jeil Bio'. It details the reasons for potential delisting (disclaimer of opinion in audit reports) and the timeline for objection and review. Since this is an official notice regarding the removal of a company's stock from the exchange, it falls under the 'Delisting Announcement' category.
2025-04-04 Korean
주권매매거래정지기간변경 (상장폐지 사유 발생)
Delisting Announcement Classification · 100% confidence The document is a formal regulatory notice regarding the suspension of stock trading for 'Jeil Bio' due to delisting-related issues. It specifies the change in the suspension period based on KOSDAQ market regulations. Since it pertains to regulatory market actions and does not fit into specific categories like 'Delisting Announcement' (which usually refers to the final notice of removal) or 'Legal Proceedings', it is best classified as a general regulatory filing.
2025-04-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.